メタ情報
| meta description平均長 | 161.2 |
|---|
| OGPありページ数 | 25 |
|---|
| Twitterカードありページ数 | 25 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 177 |
|---|
| ページあたり内部リンク平均 | 40.04 |
|---|
内部リンク 深さヒストグラム
| キー | 値 |
|---|
| 0 | 26 |
| 1 | 643 |
| 2 | 121 |
| 3 | 25 |
| 4 | 3 |
| 5 | 181 |
| 7 | 2 |
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| ahcc | 1 |
| was | 0.99995 |
| evaluation | 0.915663 |
| Publication | 0.819277 |
| infections | 0.813253 |
| HPV | 0.705174 |
| IFN | 0.53012 |
| correlated | 0.518072 |
| adverse | 0.506024 |
| eliminate | 0.46988 |
| first | 0.46988 |
| level | 0.46988 |
| Results | 0.457831 |
| phase | 0.457831 |
| once | 0.457831 |
| host | 0.457831 |
| duration | 0.457831 |
| beyond | 0.457831 |
| result | 0.457831 |
| optimize | 0.457831 |
| success | 0.457831 |
| durable | 0.457831 |
| outcomes | 0.457831 |
| suppression | 0.457831 |
| merits | 0.457831 |
| tool | 0.457831 |
| monitoring | 0.457831 |
| clearance | 0.425419 |
| tolerated | 0.397058 |
| side | 0.388869 |
| daily | 0.387604 |
| clinical | 0.373917 |
| further | 0.368696 |
| needs | 0.368696 |
| required | 0.368696 |
| negative | 0.368696 |
| effective | 0.365061 |
| immune | 0.359802 |
| persistent | 0.329247 |
| less | 0.32538 |
| https | 0.325301 |
| demonstrated | 0.317444 |
| your | 0.309746 |
| association | 0.293066 |
| more | 0.290626 |
| www | 0.289157 |
| Journal | 0.283613 |
| than | 0.283109 |
| system | 0.277802 |
| well | 0.272425 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| resulted | supplementation | 5.999187 | 1496 |
| following | resulted | 5.602819 | 1527 |
| HPV | infections | 4.873895 | 490 |
| optimize | success | 4.537851 | 152 |
| monitoring | tool | 4.537851 | 152 |
| following | supplementation | 4.523514 | 1379 |
| beyond | required | 4.514855 | 152 |
| Results | phase | 4.509181 | 152 |
| durable | success | 4.509181 | 152 |
| further | merits | 4.509181 | 152 |
| beyond | first | 4.481236 | 152 |
| negative | result | 4.453982 | 152 |
| needs | result | 4.453982 | 152 |
| durable | outcomes | 4.452566 | 152 |
| outcomes | suppression | 4.452566 | 152 |
| first | negative | 4.397367 | 152 |
| IFN | suppression | 4.393678 | 156 |
| less | level | 4.386651 | 152 |
| daily | once | 4.376038 | 152 |
| tolerated | well | 4.370504 | 168 |
| data | retrospective | 4.330034 | 136 |
| eliminate | persistent | 4.298368 | 156 |
| IFN | level | 4.289724 | 152 |
| effects | side | 4.282248 | 192 |
| base | line | 4.264009 | 108 |
| control | group | 4.257889 | 328 |
| adverse | side | 4.219069 | 160 |
| clearance | correlated | 4.214795 | 152 |
| immune | system | 4.211941 | 329 |
| data | reference | 4.196312 | 124 |
| ASCO | reference | 4.194601 | 112 |
| identity | independently | 4.164853 | 100 |
| American | Society | 4.158376 | 117 |
| compared | control | 4.114096 | 328 |
| American | rates | 4.099711 | 112 |
| here | see | 4.093478 | 100 |
| https | www | 4.060383 | 96 |
| Click | here | 4.058477 | 100 |
| Volunteers | line | 4.058477 | 100 |
| less | than | 4.055412 | 152 |
| changes | resulted | 4.044084 | 752 |
| identity | tested | 4.027205 | 100 |
| correlated | than | 4.013559 | 152 |
| changes | following | 3.95653 | 871 |
| Supplementation | rate | 3.925932 | 100 |
| Compared | against | 3.899387 | 112 |
| clinical | tool | 3.889084 | 152 |
| host | support | 3.86149 | 152 |
| following | observations | 3.791871 | 682 |
| AHCC | supplementation | 3.783882 | 1733 |